These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Growth of niche CROs specializing in rare diseases. Increasing demand for biologics and biosimilars testing. Expansion into emerging markets. Top Drug Discovery Preclinical Cro Market Companies ...

The pharmaceutical industry has long played a key role in developing treatments for a wide range of medical conditions, particularly through biologics and biosimilars such as ... In recent years, in ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

Samsung Bioepis received approval for two biosimilars of denosumab that are interchangeable with Prolia and Xgeva. Ospomyv provided similar BMD increases as Prolia for women with osteoporosis in a ...

Basel, February 24, 2025 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, announces the launch of Pyzchiva®* (ustekinumab-ttwe) in the US.From today, the ...

The UK health service has well over a decade’s experience of dealing with biosimilars, but the NHS acknowledges that it has yet to make the most of these drugs. That was certainly one of the ...

Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, Prime Standard) (“Formycon” or “the Company”) today provided an update on key developments across various biosimilar projects and invites ...

March 25, 2025 at 4 PM - Martin Krzywinski Creative Workshop Hosted by Martin Krzywinski in Rehki 112 Working on an Art in Silico submission and would like an extra set of expert eyes? Working on a ...

It calls the new drug “Merilog,” a biosimilar to the widely-used insulin product Novolog (insulin aspart). A biosimilar is highly similar to that reference with no clinically meaningful ...